Today, a Working Visit (Tinjauan Tapak Projek) took place at Gate G1, KL International Airport (KLIA). The purpose of this Tinjauan Tapak Projek is to prepare the smooth running of the new COVID-19 Screening Facility where passengers travelling through KLIA will undergo COVID-19 screening tests soon. B.P. Clinical Lab. Sdn. Bhd. through its collaboration with Malaysia Airports will be providing state-of-the-art COVID-19 screening facilities at KLIA which includes an onsite COVID-19 laboratory in the Airport itself. This will allow test results to be churned out much quicker and passengers can therefore look forward to a shorter waiting time upon arrival.
BP Clinical Lab has the capability to produce RTK-Ag results targeted within 15 minutes and RT-PCR screening test results targeted within 3 hours. Symptomatic passengers shall be segregated in designated isolation bays. If positive, they will be transferred to hospital accordingly. It is worth mentioning that this COVID-19 screening facility will not provide Inpatient or Outpatient treatment for COVID-19 detected passengers.
Among the facilities and services that will be provided include passenger escort from the arrival gate to the testing area, VIP service, as well as relaxing and comfortable waiting lounges. The lounges are equipped with productivity tools such as computers, Wi-Fi Internet access, portable WiFi rental and telecommunication SIM card, OTC pharmaceutical products, basic personal protective items like masks and face shields as well as F&B offerings. As the passenger load increases, BP Clinical Lab and Malaysia Airports will establish more COVID-19 Health Screening Lounges at other gates within the Airport to cater to the increased load.
CEO of BP Clinical Lab and Executive Director of BP Healthcare, Mr Garvy Beh said, “This collaboration is timely as the nation prepares to reopen its borders. Our aim is to ensure that all passengers entering the country are duly screened to protect the health and safety of our citizens. We are very pleased to be partnering with Malaysia Airports to provide Covid-19 tests and related value-added services to all passengers at the airports. With this, we hope that travellers can travel safely, comfortably and with peace of mind. Since the start of the Covid-19 pandemic, BP Healthcare has conducted multi-million RT-PCR tests nationwide. All our tests are recognized and of GOLD-STANDARD recommended by MOH, IMR and FDA.”
Passengers will be able to pre-purchase their COVID-19 screening tests before departure on https://malaysiaairports.doctor2u.my/ , the one-stop e-commerce platform that supports hundreds of different e-payment options as well as insurance claims ensuring a “Total Solution” and seamless travel experience for all passengers entering Malaysia. To ensure staff safety and wellbeing, BP Clinical Lab will also be offering free COVID-19 RT-PCR screening tests to all its staff and has over 200 staff to operate the COVID-19 screening facility. The staff manpower will be increased as and when the passenger load increases.
BP Healthcare is always at the forefront of lab technological development and both Malaysia Airports and BP Clinical Lab are confident that the COVID-19 testing time can be further shortened with the advancement of the technology.
BP Clinical Lab was appointed by Malaysia Airports to provide the services and facilities at KLIA after a stringent tender exercise. BP Clinical Lab has over 38 years’ experience in the medical healthcare industry and has a proven track record in providing services to many government agencies such as MOH and Social Security Organisation (SOCSO). BP Healthcare Group has more than 120 outlets nationwide and a large pool of medical personnel comprising qualified doctors and nurses, and the current health check system is also integrated with MySejahtera and SIMKA (owned by the National Public Health Laboratory to monitor outbreaks). To date, BP Clinical Lab has conducted multi-million COVID-19 RT-PCR screening tests.
About BP Healthcare
BP Healthcare Covid-19 Experiences & Credentials
CONDUCTED MULTI-MILLION RT-PCR MOLECULAR TESTS
DAILY 80K RT-PCR CAPACITY
40 YEARS EXPERIENCE AND SERVING MULTI MILLIONS CUSTOMERS YEARLY
NATIONWIDE LINKED
ISO 15189 & JCI ACCREDITATION (1ST IN ASIA -THIRD CYCLE)
SPECIAL CSR FREE SCREENING TO ALL OKUS NATIONWIDE, AND 50% DISCOUNT FOR SENIOR CITIZENS (>60 Y/O) AND ANYONE AGED 20 AND BELOW
Across the nation and beyond, since its inception 40 years ago, BP Healthcare Group has now grown to over 120 outlets in 3 different countries. BP Healthcare covers an extensive range of services, including its BP Specialist and Diagnostic Centres, Pharmacy, Food and Environmental testing, Waste Management, Hearing Solutions, Sleep Centres, and health technology arm, Doctor2U. BP’s infrastructures and facilities are highly accredited, with all its laboratories having ISO 15189 and International JCI Status.
BP Healthcare Centres nationwide are SOCSO panel clinics and BP Clinical Lab is a panel Covid-19 lab to the Kementerian Kesihatan Malaysia (KKM). Since May 2021, BP Healthcare has been a panel COVID-19 vaccine administrator under the National COVID-19 Immunization Programme overseen by ProtectHealth Corporation Sdn Bhd and has to date administered over hundreds of thousands of COVID-19 vaccinations to the rakyat at PWTC Vaccination Centre as well as many other BP Healthcare outlets nationwide.
B.P. Clinical Lab Sdn. Bhd. (BP Clinical Lab) (Company No: 198601003161; 152314-H) commenced its business as a provider of medical laboratory testing services and analyses in the 1980's.
Through its network of laboratories, BP currently serves thousands of private medical practitioners, private and public hospitals throughout the country and generates millions of test results. BP Lab also serves as a panel laboratory for some corporations and insurance companies.
Test methodologies, media and laboratory equipment are constantly being evaluated and updated to keep abreast with the state-of-the-art instrumentation and to improve the efficiency of test procedures with faster turnaround time. With our philosophy of meeting challenges through continuous delivery of quality service and assurance of customer satisfaction, BP Lab has today become one of the leading key players in the clinical laboratory. In response to the current COVID pandemic, BP has established a molecular laboratory designated to COVID RT-PCR test.
Through our adaptability and responsiveness to changes and our culture of work excellence, we are confident that we can maintain our reputation and position in the coming years.
As an effective quality management system is the cornerstone for the delivery of safe patient care and accurate laboratory test results, the management of BP Healthcare is highly committed to ensuring the laboratories are accredited to relevant quality management standards.
All of BP Healthcare Group’s IT systems are internally developed and supported by Doctor2U, the IT arm of the Group. Doctor2U was initially established in 2015 to serve the internal IT needs of the Group. Over time, due to overwhelming public demand, we started extending our services to outside of the Group. Today, we have over 10 million users on our platform comprising key healthcare services including Doctor Home Services, Medication Delivery, Live Chat, Tele-Medicine, Ambulance, E-commerce, Electronic Medical Report, Nursing and Physiotherapist Home Services.
Doctor2U’s aim is to be the one-stop health platform which connects all key stakeholders in a person’s healthcare journey – the Doctor2U App connects doctors, patients, pharmacies, insurance companies and employers, making it seamlessly easy and convenient for all. Our Microsoft-powered Electronic Medical Record (EMR) feature allows patients to view their Lab results, Radiology reports and images, doctors’ notes, prescriptions, and any other medical record on a single platform – anytime anywhere! We use Microsoft Azure, a HIPAA and GDPR compliant platform to power our entire Doctor2U IT ecosystem.
Significant Achievements in 2020
Successfully integrated with various government and corporate IT systems including PERKESO, MYSEJAHTERA, SIMKA, GHL and MYEG to provide seamless and effective management of Covid-19 screening test appointments and test results.
Our shop.doctor2u.my has facilitated almost 2 million bookings from PERKESO, Corporates, Insurance Providers, MYEG, MOH and various other organisations for Walk-In and Onsite screening as well as outsourced testing since March 2020. Platform handled bookings, payments, result release and viewing by Patients and Corporates.
We have a robust laboratory information system (LIS) that is fully cloud-based and is interfaced with all our Covid-19 equipment (Roche). All processes are QR coded, from moment of arrival at Covid-19 lab, to release of results onto our linked Doctor2U Portal. Customers and patients can view their COVID-19 results seamlessly via e-mail and Doctor2U mobile App.
On 23 December 2020, BP-Doctor2U successfully went live with Singapore Temasek’s Affinidi. All BP customers who undergo Covid-19 screening tests at any BP outlet can now use their BP test results QR Code as a secure digital verification at Singaporean airlines, immigration, and checkpoints authority recognised by the Ministry of Health, Singapore.
This content is provided by Ali Health Sdn Bhd.
Interested in having your announcements on Malaysiakini? Contact the announcements team at [email protected] or whatsapp on +60 17-323 0707 for urgent matters.
